Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health 2025-10-28 17:00
Samsung Biologics reports third quarter 2025 financial results 2025-10-28 14:50
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC 2025-10-28 09:46
JSBio Strengthens Commitment to Power Cellular Agriculture Commercialization 2025-10-28 09:00
Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program 2025-10-28 08:00
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program 2025-10-27 21:00
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner 2025-10-27 19:15
China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392) 2025-10-27 19:00
MINISH Technology Has Successfully Concluded Its First U.S. MINISH Veneers Course, Certifying 22 Dentists 2025-10-27 14:58
Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials 2025-10-27 13:22
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE) 2025-10-27 11:23
Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025 2025-10-27 09:00
Indonesia's Legacy in the Global Vaccine Landscape, Bio Farma and DCVMN Strengthen Health Resilience Through Global Partnership 2025-10-25 18:52
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement 2025-10-25 15:00
A Self-Reliant Future through HPV 9-Valent Vaccine Alliance: INNOVAX details Localization Strategy in Thailand at IPVS 2025 2025-10-24 20:20
Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection 2025-10-24 18:12
Pfizer and BioNTech Receive Health Sciences Authority Approval for SARS-CoV-2 Sublineage LP.8.1-Adapted Monovalent COVID-19 Vaccine in Singapore 2025-10-24 17:33
Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website 2025-10-24 16:40
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022 2025-10-24 12:56
HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity 2025-10-24 07:30